I've just had a quick look at the announcements around this time last year - it's quite depressing really.
Firstly there was no CC with the April 4C...
But, apart from that what a difference a year makes
This time last year, we had a lot of exciting news and everything was looking promising.
This year, in April so far - no news.
C'mon Mesoblast - organise a CC with the April quarterly and give us the landscape.
Even if there's nothing official to announce - just explain what is being worked on and the progress/ challenge relating to each of these big ticket items:
- Ryoncil
- C19 ARDS
- Novartis
- CHF data, partnerships - existing and any new developments
- CLBP data, partnerships - existing and any new developments
- SurgeCenter - provide a bit more details - why did they invest etc
I'm a huge supporter of Mesoblast and still live in hope - but, I need some explanations.
As the silence has been deafening
The SP performance only exacerbate this negativity
MSB Trading 2021 - paradigm shift, page-3892
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |